<DOC>
	<DOC>NCT00539578</DOC>
	<brief_summary>The purpose of the study is to examine the safety and efficacy of MK0777 during treatment for Generalized Anxiety Disorder.</brief_summary>
	<brief_title>Treatment of Patients With Anxiety Disorder (0777-022)</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<criteria>Male and Female patients ages 18 to 70 Women who are breastfeeding or pregnant Positive result at prestudy on urine drug screen for illicit drugs History of alcohol or drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>